Biblio
Export 223 results:
Author Title [ Type] Year Filters: First Letter Of Title is E [Clear All Filters]
“The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1299-310, 2016.
, “Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration.”, J Alzheimers Dis, vol. 56, no. 3, pp. 885-891, 2017.
, “The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.”, J Alzheimers Dis, vol. 56, no. 2, pp. 805-815, 2017.
, “The Effect of Traumatic Brain Injury History with Loss of Consciousness on Rate of Cognitive Decline Among Older Adults with Normal Cognition and Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 59, no. 1, pp. 251-263, 2017.
, “Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.”, J Alzheimers Dis, vol. 49, no. 2, pp. 493-502, 2016.
, “Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.”, J Alzheimers Dis, vol. 56, no. 2, pp. 575-584, 2017.
, “Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1131-1139, 2017.
, “Effectiveness of a Personalized Brain-Computer Interface System for Cognitive Training in Healthy Elderly: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 66, no. 1, pp. 127-138, 2018.
, “Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer's Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1035-1044, 2018.
, “Effectiveness of Exercise- and Cognitive-Based Treatments on Salivary Cortisol Levels and Sundowning Syndrome Symptoms in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1631-40, 2016.
, “The Effectiveness of GRADIOR: A Neuropsychological Rehabilitation Program for People with Mild Cognitive Impairment and Mild Dementia. Results of a Randomized Controlled Trial After 4 and 12 Months of Treatment.”, J Alzheimers Dis, vol. 86, no. 2, pp. 711-727, 2022.
, “The Effectiveness of Psychosocial and Behavioral Interventions for Informal Dementia Caregivers: Meta-Analyses and Meta-Regressions.”, J Alzheimers Dis, vol. 66, no. 1, pp. 149-172, 2018.
, “Effectiveness of Supporting Informal Caregivers of People with Dementia: A Systematic Review of Randomized and Non-Randomized Controlled Trials.”, J Alzheimers Dis, vol. 52, no. 3, pp. 929-65, 2016.
, “The Effects and Meanings of Receiving a Diagnosis of Mild Cognitive Impairment or Alzheimer's Disease When One Lives Alone.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1517-1529, 2018.
, “Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Functions in Older Subjects with Increased CAIDE Dementia Scores.”, J Alzheimers Dis, vol. 64, no. 1, pp. 71-78, 2018.
, “Effects of a 6-Month Multifaceted Diet and Exercise Intervention on Cognition in Older Adults at Risk of Cognitive Decline: The PONDER Double-Blind, Placebo-Controlled Randomized Trial.”, J Alzheimers Dis, vol. 89, no. 1, pp. 247-263, 2022.
, “Effects of a DJ-1-Binding Compound on Spatial Learning and Memory Impairment in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 67-72, 2017.
, “Effects of a Physical Activity Program that Incorporates Exercises Targeting Balance, Strength, and Proprioception on Cognitive Functions and Physical Performance in Old Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 96, no. 1, pp. 245-260, 2023.
, “Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-β Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.”, J Alzheimers Dis, vol. 55, no. 3, pp. 995-1003, 2017.
, “The Effects of Amnestic Mild Cognitive Impairment on Go/NoGo Semantic Categorization Task Performance and Event-Related Potentials.”, J Alzheimers Dis, vol. 50, no. 2, pp. 577-90, 2016.
, “The Effects of an APOE Promoter Polymorphism on Human White Matter Connectivity during Non-Demented Aging.”, J Alzheimers Dis, vol. 55, no. 1, pp. 77-87, 2017.
, “The Effects of APOE4 on Mitochondrial Dynamics and Proteins in vivo.”, J Alzheimers Dis, vol. 70, no. 3, pp. 861-875, 2019.
, “Effects of Brain Pathologies on Spatiotemporal Gait Parameters in Patients with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 96, no. 1, pp. 161-171, 2023.
, “The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1255-1267, 2017.
, “Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1767-1775, 2018.
,